Network meta-analysis with dose-response relationships

Read full text
Authors: Μαρία Πετροπούλου, Gerta Rücker, Guido Schwarzer
Cited by: 5
References: 43

Abstract

BACKGROUND: Network meta-analysis (NMA) is a widely used method for synthesizing evidence from multiple interventions for a medical condition. However, NMA applications typically ignore the crucial role of drug dosage on intervention effects. Traditional NMAs either consider each intervention dose as an independent node or ignore the intervention dose, which may impact heterogeneity, inconsistency, or sparsity. METHODS: This paper introduces a novel frequentist approach, termed dose-response network meta-analysis (DR-NMA), which explicitly models the dose-response relationships across multiple interventions. The DR-NMA approach incorporates both linear and nonlinear dose-response relationships, including exponential, quadratic, fractional polynomials, and restricted cubic splines. DR-NMA allows for dose-dependent estimation and prediction of treatment effects across dose ranges, even in disconnected networks if common agents exist. The proposed methods are implemented in the R package netdose, enhancing accessibility and reproducibility. We illustrate the approach using clinical datasets on postoperative nausea and vomiting, as well as antidepressant treatments. RESULTS: Our findings indicate that some dose-response NMA models yield substantially different results compared to standard NMA, emphasizing the critical importance of dose-response function selection in model performance. CONCLUSIONS: DR-NMA provides valuable insights into the dose-dependent effects of interventions, enhancing decision-making and offering perspectives beyond traditional methods.

Fields of Study & Subjects

Meta-analysis and systematic reviews Treatment of Major Depression Statistical Methods in Clinical Trials

Publication details

Journal / source
BMC Medical Research Methodology
Publisher
Springer Science and Business Media LLC
Volume
26
Issue
1
Pages
17–17
Publication date
13 January 2026
Language
EN